Pacific Biosciences Of California (PACB) Gross Margin (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Gross Margin of 34.54% for Q1 2026, up 3823.0% year-over-year from 0.88% in Q1 2025, and down 6.92% quarter-over-quarter from 37.11% in Q4 2025.
Pacific Biosciences Of California (PACB) Gross Margin (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Gross Margin history runs 17 years deep, the most recent figure standing at 34.54% for Q1 2026.
- In Q1 2026, Gross Margin rose 3823.0% year-over-year to 34.54%; the TTM figure through Mar 2026 stood at 37.49% (up 2132.0% YoY), while the FY2025 annual figure was 28.61%, up 440.0% from the prior year.
- Gross Margin for Q1 2026 stood at 34.54%, down from 37.11% in the prior quarter.
- The five-year high for Gross Margin was 45.66% in Q2 2022, with the low at 3.69% in Q1 2025.
- The 5-year median for Gross Margin is 32.15% (2023), against an average of 29.28%.
- The sharpest annual moves came in 2025 and 2026: Gross Margin tumbled 3276 bps in 2025, then surged 3823 bps in 2026.
- Pacific Biosciences Of California's Gross Margin stood at 18.79% in 2022, then fell by 13 bps to 16.4% in 2023, then soared by 56 bps to 25.64% in 2024, then surged by 45 bps to 37.11% in 2025, then dropped by 7 bps to 34.54% in 2026.
- Business Quant data shows PACB's Gross Margin at 34.54% in Q1 2026, 37.11% in Q4 2025, and 41.36% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.84% |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | 32.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.40% |
| Mar 31, 2026 | 34.54% |
| Dec 31, 2025 | 37.11% |
| Sep 30, 2025 | 41.36% |
| Jun 30, 2025 | 36.93% |
| Mar 31, 2025 | -3.69% |
| Dec 31, 2024 | 25.64% |
| Sep 30, 2024 | 25.03% |
| Jun 30, 2024 | 16.49% |
| Mar 31, 2024 | 29.07% |
| Dec 31, 2023 | 16.40% |
| Sep 30, 2023 | 32.15% |
| Jun 30, 2023 | 32.68% |
| Mar 31, 2023 | 25.09% |
| Dec 31, 2022 | 18.79% |
| Sep 30, 2022 | 41.93% |
| Jun 30, 2022 | 45.66% |
| Mar 31, 2022 | 42.67% |
| Dec 31, 2021 | 46.55% |
| Jun 30, 2021 | 44.93% |